Characteristics and Consequences of Coronary Angiograms Performed in Intensive Care Patients

Acute Coronary Syndrome Clinical Trial

— Coro-ICU  

Official title:

Characteristics and Consequences of Coronary Angiograms Performed in Intensive Care Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05529810
• Other study ID #: 8639
• Status: Completed
• Start date: May 30, 2022
• Est. completion date: July 30, 2023

Study information

• Verified date: December 2023
• Source: University Hospital, Strasbourg, France
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Coronary angiography is a key examination in the management of many patients hospitalized in intensive care units. The most frequent indication remains the performance of a gesture of unblocking of part of the coronary network in the context of an acute coronary syndrome (ACS) complicated by cardiogenic shock (CS) and/or cardiac arrest. cardio-respiratory (ACR). However, there are other indications in intensive care, in particular for diagnostic purposes. Given the lack of harmlessness of this procedure in itself and the consequences of intra-hospital transport outside intensive care units for patients who are sometimes very unstable, the risk-benefit balance before performing a coronary angiography requires always be properly assessed by the resuscitating physician.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 150
• Est. completion date: July 30, 2023
• Est. primary completion date: December 30, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria:

• Adult patient (=18 years old)

• Patients hospitalized in Intensive Medicine - Resuscitation between January 1, 2015 and January 1, 2020 in whom a coronary angiography was performed.

• Patient not objecting to the reuse of their data for scientific research purposes.

Exclusion criteria:

• Patient who has expressed his opposition to the reuse of his data for scientific research purposes.

Related Conditions & MeSH terms

• Acute Coronary Syndrome

Locations

Country	Name	City	State
France	Service de Médecine Intensive - Réanimation - CHU de Strasbourg - France	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of complications occurring in the 3 days following the performance of a coronary angiography during their stay in the intensive care unit		3 days following the performance of a coronary angiography during their stay in the intensive care unit